Biotech & Life Sciences Investor Relations episode artwork

EPISODE · Aug 30, 2025 · 1 MIN

Biotech & Life Sciences Investor Relations

from The Investor Relations Podcast · host Joshua Wilson

In this episode of The Investor Relations Podcast, Michael Loftus, Biotech Growth Architect and Family Office Strategist, shares his perspective on what makes investor relations effective in the fast-moving world of life sciences. Drawing from his experience at the intersection of biotech investing, clinical trials, and family office strategy, Michael explains how companies can strengthen relationships with investors and avoid common pitfalls.The conversation explores why biotech companies must prioritize consistent communication, transparency, and brand awareness to stand out in a crowded field. Michael also highlights the importance of tailoring outreach to specialized investors instead of taking a broad “spray and pray” approach. For executives, IR officers, and capital markets professionals, this discussion provides actionable insights into building credibility, trust, and long-term partnerships within biotech and life sciences.Connect with the GuestCompany: https://www.poccap.comLinkedIn: https://www.linkedin.com/in/mikeloftusclinicaltrials/Podcast profile: View all of their episodes hereConnect with the HostJoshua Wilson LinkedIn: https://www.linkedin.com/in/joshuabrucewilson/The Investor Relations Podcast YouTube channel: https://www.youtube.com/@TheInvestorRelationsPodcast#InvestorRelations #Biotech #LifeSciences #CapitalMarkets #FamilyOffice #ShareholderEngagementDisclaimer: Joshua Wilson is a licensed Florida real estate broker and holds FINRA Series 79 and Series 63 licensure. The content of this podcast is for informational and educational purposes only and should not be considered legal, financial, or compliance advice. All views and opinions expressed by the host and guests are their own and do not necessarily reflect the policies or positions of any regulatory agency, organization, or employer. Listeners should consult their own legal counsel, compliance teams, or financial advisors to ensure adherence to applicable regulations, including SEC, FINRA, and other industry-specific requirements. This podcast does not constitute a solicitation or recommendation for any financial products or services.Let’s Connect on LinkedIn:https://www.linkedin.com/in/joshuabrucewilson/To Contact Us, Please Visit:https://www.theinvestorrelationspodcast.com/contact/

Episode metadata supplied by the publisher feed · Published Aug 30, 2025

Embed this episode

In this episode of The Investor Relations Podcast, Michael Loftus, Biotech Growth Architect and Family Office Strategist, shares his perspective on what makes investor relations effective in the fast-moving world of life sciences. Drawing from his experience at the intersection of biotech investing, clinical trials, and family office strategy, Michael explains how companies can strengthen relationships with investors and avoid common pitfalls. The conversation explores why biotech companies m...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Biotech & Life Sciences Investor Relations

0:00 1:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Investor Relations Podcast?

This episode is 1 minute long.

When was this The Investor Relations Podcast episode published?

This episode was published on August 30, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this The Investor Relations Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!